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1. There is a dramatic downregulation of a-actin and vimentin microfilaments in athero- 
sclerotic plaque. 
2. OxLDL markedly downregulates VSMC a-actin and vimentin expression via a PPARy 
and ~38 MAPK Independent pathway. OxLDL regulation of VSMC cytoskeletal pro- 
teins may play a critical role in afherogenesis through alterations In cell motility, differ- 
entiation and growth. 
1200-l 38 Intravascular Detection of lnflammed Atherosclerotic 
Plaques With a Novel Macrophage-Targeted 
Fluorescent Photodynamic Compound 
Ahmed Tawakol, Alan Fischman, Henry Gewirtz, James E. Muller, Thomas Brady, 
Michael Hamblin, Mass General Hospital, Boston, MA 
Background: Vulnerable plaques contain abundant macrophages. We developed a 
novel photodynamic agent, chlorin, conjugated with maleylated albumin, (ce6-mal-alb) 
that concentrates in macrophage-rich plaques and has a high fluorescent yield. As such, 
we tested hypothesis that experimental atherosclerotic lesions (ATHERO) can be 
detected using ce6-mal-alb and an intravascular fluorescence spectroscopy catheter. 
Methods: ATHERO were induced in New Zealand rabbits by infradiaphragmatic aortic 
balloon-injury followed by high cholesterol diet. At IO weeks, ce6-mal-alb was adminis- 
tered to 7 atherosclerotic and 7 control animals. 24 hours later, aortic uptake of the ce6- 
mal-alb uptake was measured in situ, using an intravascular fluorescence spectroscopy 
catheter. Thereafter, the aortas were excised and dissolved in NaOH/SDS for spectroflu- 
orimetric determination of ce6 content. 
Results: Intravascular measurements of ce6-mal-alb fluorescence were higher in 
ATHERO vs. non-athero segments, (8.8i4.8 vs. 2.2k2.2 X103AU, P<O.OOl, figure). Fur- 
ther, ce6-mal-alb concentration was higher within the ATHERO aortas (5.2t3.2 vs. 
1.9+1.2, ce6 fluorescencelgm tissue x IOs, p=<O.Ol). Conclusion: CeG-mal-alb can be 
employed for intravascular characterization of atherosclerotic plaques. Because this 
novel PDT compound is selectively toxic to macrophages when light-activated, this agent 
may be useful for both the detection and therapeutic modification of macrophage-rich 
plaques. 
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1200-l 39 Endogenous Free Radical Generating Sources Are 
Involved in Smoking-Mediated Dysfunction of Nitric 
Oxide Biosynthesis in Human Coronary Artery 
Endothelial Cells: An In Vitro Demonstration 
Sudhesh K. Srivastava, Rajat S. Barua, Dhanonjoy C. Saha, Lesley-Jane Eales- 
Reynolds, Mary C. DeVoe, John A. Ambrose, Saint Vincent Catholic Medical Centers of 
New York, New York, NY, School of Biomedical and Life Sciences, University of Surrey, 
Guildford, United Kingdom 
Backgromd We have previously demonstrated that cigarette smoking alters NO bio- 
synthesis by reducing NO availability and eNOS activity while increasing eNOS protein 
expression. Although oxidative stress has been proposed as the leading mechanism for 
these changes, the source of free radicals is unclear. Cigarette smoke contains high lev- 
els of free radicals. However, free radicals potentially arise from endogenous sources as 
well. This study investigated the role of endogenous free radical generating sources in 
smoking-related dysfunctional NO biosynthesis in human coronary artery endothelial 
cells (HCAECs). 
Methods and Results Confluent (-85%) monolayers of HCAECs were incubated with 
serum from 6 nonsmokers and 8 smokers for 12 hours with or without the addition of 
either IOOuM LNMMA, 30uM apocyamn (NADPH oxidase inhibitor), 1OOuM allopurinol 
(xanthine oxidase inhlbitor) or 2uM rotenone lmitochondrial electron transporl chain 
(METC) inhibitor]. Following incubation, NO levels and eNOS protein expression were 
measured from the same culture by standard techniques. HCAECs incubated with smok- 
ers’ serum alone showed significantly lower NO level (O.OZ+O.Olversus 0.13*0.02 uM/pg 
eNOS/mg total protein, P<O.O07) and higher eNOS expression (P<O.OOS) compared to 
nonsmokers. In smokers, only allopurinol (0.04*0.01 uM/pg eNOS/mg total protein) or 
rotenone (0.06*0.01 uM/pg eNOS/mg total protein) treatment significantly +0.05) 
improved NO availabillty. However, levels were still lower compared to nonsmokers 
(P<O.O5). Interestingly, when smokers’ serum was treated with combined rotenone. 
allopurinol and 20uM tetrahydrobiopterin (an eNOS cofactor) the NO level, eNOS 
expression and eNOS activity normalized to that of nonsmokers. 
Conclusions To our knowledge this is the first demonstration that endogenous free 
radical generators such as xanthine oxidase, the METC and eNOS contribute to smok- 
ing-mediated dysfunction of NO biosynthesis. 
1200-140 Synergistic Effect of Urotensin II With Serotonin on 
Vascular Smooth Muscle Cell Proliferation 
Takuva Watanabe, Takashi Katagiri, Rajbabu Pakala, Claude R. Benedict, Showa 
University School of Medicine, Tokyo, Japan, University of Texas-Houston Medical 
School, Houston, TX 
Background: Urotensin II (U-II), the most potent vasoconstrictor known to date, and sero- 
tonin (5-HT) have been recently shown to play an important role in pulmonary hyperten- 
sion. However, little is known about the effect of U-II and its interaction with 5.HT on 
vascular smooth muscle cell (VSMC) proliferation. We assessed the interaction between 
U-II and 5.HT in inducing VSMC proliferation. 
Methods: Growth-arrested rabbit VSMCs were incubated in serum-free medium with dif- 
ferent concentrations of U-II and 5-HT. VSMC proliferation was examined by the 
increase in [SHlthymidine incorporation into cellular DNA and cell number. 
Results: U-II or 5.HT induced [3H]thymidlne incorporation in a concentration-dependent 
manner with a maximal effect at a concentration of 50 nanoM (I 61%) or 50 microM 
(205%), respectively. When added together, low concentrations of U-II (50 nanoM) and 
5-HT (1 microM) interacted synergistically in inducing [SH]thymidine incorporation 
(382%). These effects on [SH]thymidine incorporatlon were paralleled by an increase in 
cell number. The G-protein inactivator GDP-beta-S (100 microM), protein kinase C (PKC) 
inhibitor Ro31-8220 (0.1 microM), c-Src tyrosine kinase inhibitor PP2 (I microM), and 
mitogen-activated protein kinase (MAPK) kinase inhibitor PD098059 (IO microM) signifi- 
cantly inhibited the mitogenic effects of U-II and 5-HT and also their interaction in induc- 
ing [3H]thymidine incorporabon. 
Conclusion: Our results suggest that U-II and 5-HT may induce the synergistic interaction 
in inducing VSMC proliferation via a G-protein-coupled receptor/PKClc-Src tyrosine 
klnase/MAPK pathway, thtis contributing to the relatively rapid development of athero- 
sclerosis in hypertensive vascular disease. 
1200-141 Systemic Inflammation: Independent Predictor of 
Contrast Induced Nephropathy 
Harish R. Chandra, Peter Kim, James A. Goldstein, Mehrdad H. Sadeghi, William W. 
O’Neill, William Beaumont Hospital, Royal Oak, MI 
Background: Recent observations demonstrate that systemic inflammation may exert 
adverse influence throughout the vascular bed. This study was designed to determine 
whether there is a relationship between the presence and magnitude of systemic inflam- 
mation and contrast induced nephropathy in patients undergoing coronary angiography. 
Methods: In 244 patients undergoing coronary angiography we analyzed the association 
between systemic markers of inflammation (high sensitivity C-reactive protein, CRP) and 
contrast Induced nephropathy (GIN) defined as decrease in creatinine clearance (CC) of 
al least 25 cclmin. Univariate and multivariate analysis were performed. 
Results: Mean age of the patients was 62+13 yrs and 61% we males. Baseline CC was 
89 cclmin. 82% underwent angiography for acute coronary syndrome. 8% developed 
CIN following the angiography. 2% of the patients in the first tertile of CRP develped CIN 
compared to 12% in second and 13% in the third tertile of CRP, p=O.O3. On multivariate 
analysis higher CRP tertile was an independent predictor of CIN (OR 2.8, p=O.OZ) along 
with use of intra-aortic balloon pump (OR=9.3, p=O.O4) and baseline creatinine clearance 
(OR=1.04, p<O.OOOl). 
Conclusion: These findings demonstrate a strong association between the presence and 
magnitude of systemic inflammation and development of contrast induced nephropathy. 
1200-l 42 Stabilization of Plaque Size Accompanied by a Time 
Dependent Decrease in Activated Macrophage Content 
After Vascular Injury in the Apolipoprotein-E Null 
Mouse 
Christopher J. Davis, Joshua J. Fischer, John M. Sanders, Daniel K. Bennett, Ian J. 
Sarembock, University of Virginia Health System, Charlottesville, VA 
Background: Apolipoprotein-E knockout (ApoE’) mouse models have been used to 
study atherosclerosis and responses to vascular injury. Wire injury of the carotid artery 
results in characteristic neointima formation 28 days after injury. The purpose of this 
study was to characterize plaque size and cellular content at 2 and 3 months after carotid 
injury to identify changes in lesion progression. 
Methods: Sixteen female ApoE-‘- mice were fed a Western diet for one week prior to 
wire denudation of the left common carotid artery and continued on the atherogenic diet 
for 4 weeks. After 4 weeks, they were fed a chow diet until sacrifice. Mice were eutha- 
nized at 2 months (n=8) and 3 months (n=8) after injuty and fasting blood was taken for 
glucose and cholesterol measurements. Vessels were harvested and paraffin embedded 
for morphology and immunocytochemistry. The results were compared to 1 month histor- 
ical controls. 
Results: At 1 month, plaque size was 30,500 * 5,300 pm2 , macrophage content was 
21+ 5 %. and cholesterol level was 1170 r 210 mg/dl. At 2 and 3 months, neolntimal 
areas were not statistically different (35,177 * 6,789pd vs. 29.196 * 7,31 2pm2 respec- 
tively) and similar to the 1 month group. The presence of activated macrophages in the 
neointima was significantly higher at 2 months compared to 3 months (26.2 f 5.7 % Vs 
4.2 * 1.5 %. p = ,002). There were no significant differences in mean glucose and choles- 
terol levels at 2 and 3 months (107 * 7 vs. 108 * 11 mg/dl and 427 * 20 vs. 435 * 35 mg/ 
dl respectively). 
